BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

Fujitsu Develops Advanced AI to Transform Medical Diagnostics with Multimodal Data Integration

Fujitsu announced the development of explainable AI technology that automatically draws on data in multiple formats, including text, images, and nume...

May 13, 2024 | News

Arcellx and Kite Announce Phase 3 Trial for Anito-cel in Multiple Myeloma Patients

-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMi...

May 10, 2024 | News

GHIT Fund Allocates JPY 1.64 Billion to Combat Malaria and Neglected Tropical Diseases Through Innovative Partnerships

The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...

May 09, 2024 | News

GE HealthCare Introduces SIGNA MAGNUS, Pioneering Head-Only MRI Scanner for Neuroscience Breakthroughs

GE HealthCare unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, whic...

May 06, 2024 | News

HanAll Launches Phase III VELOS-4 Trial for Tanfanercept in Dry Eye Treatment

HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Pha...

May 06, 2024 | News

Thermo Fisher Scientific Launches Innovative Urine Test for Kidney Transplant Monitoring

For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of r...

May 03, 2024 | News

Shineco Launches Innovative Product to Transform Healthcare

Shineco, a provider of technologically advanced healthcare products and services, announced that its subsidiaries Fuzhou Medashan Biotechnology Co., Ltd. a...

May 02, 2024 | News

AriBio Secures EMA Approval for Pivotal POLARIS-AD Alzheimer's Trial, Aligning with FDA and MHRA

AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzh...

April 30, 2024 | News

GE HealthCare Gains FDA 510(k) Clearance for Advanced Portrait VSM Vital Signs Monitor

GE HealthCare announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor...

April 30, 2024 | News

C₂N Diagnostics Partners with Mediford Corporation to Expand Alzheimer's Research Services in Japan

-C₂N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a part...

April 29, 2024 | News

PolyU Partners with ZEISS Vision Care to Advance Global Myopia Control

The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalm...

April 26, 2024 | News

Eisai Launches Injectable Fycompa in Japan for Epilepsy Treatment

Eisai Co., Ltd. announcedthat the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (I...

April 19, 2024 | News

Gilead Sciences Invests US$4 Million in Global Fight Against Viral Hepatitis

Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant World Hepatitis Allianc...

April 16, 2024 | News

Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography

Bayer and Hologic,announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two companies ...

April 15, 2024 | News

Stay Connected